Council of Trustees

Committees and Panels

Council of Trustees

The strategy of the Biochemical Society is set and driven by its Council of Trustees, which is elected by members and has the ultimate responsibility for all aspects of the Society’s activities.

Membership Committee Governance Executive Management Committee Finance Committee Audit Committee Awards Committee Grants Committee Conferences Committee Education, Training and Public Engagement Committee Nominations Panel Early Careers Advisory Panel Equality, Diversity and Inclusion (EDI) Panel Policy Advisory Panel Industry Advisory Panel Publications Committee Portland Press Limited Board

Council of Trustees

View Terms of Reference

Committees and Panels

13 members

Society President / Chair of Council of Trustees

Professor Dame Julia Goodfellow

Society President

Chair of Council of Trustees

Industry Representative / GSK plc

Dr Augustin Amour

Industry Representative

GSK plc

After obtaining a PhD in Paris in 1996 on the characterisation of novel neutrophil elastase inhibitors in COPD models, Gus pursued a post-doc in Cambridge where he characterised novel metalloproteinases with potential therapeutic applications for arthritis. In 1999, he joined GSK and led a team of assay scientists. In 2006 he transitioned to GSK’s Respiratory Therapy Area where he led multiple projects, and he now applies his experience gained on Respiratory projects to novel targets for various immune-related indications. Gus has deep expertise in molecular pharmacology and is experienced working with various immune cells, having authored over 50 publications and patents.

In addition to being a Biochemical Society Trustee and chairing the Society’s Industry Advisory Panel, Gus is also an Industry advisor to the EU-Openscreen consortium and a GSK scientific fellow, who enjoys mentoring the next generation of scientists.